Wanbang Pharmaceutical (301520.SZ): Hefei Qunxiang plans to invest 10 million yuan in private equity funds to lay out the cell and gene industry

Zhitongcaijing · 11/26 12:01

Zhitong Financial App News, Wanbang Pharmaceutical (301520.SZ) announced that the company-controlled Hefei Qunxiang Qi Ming Enterprise Management Partnership (Limited Partnership) (“Hefei Qunxiang”) signed the “Shenzhen Songhe Cell and Gene Industry Private Equity Investment Fund Partnership (Limited Partnership) Partnership Agreement” and related documents with Shenzhen Songhe Capital Management Co., Ltd. and other parties on November 22, 2024. Hefei Qunxiang subscribed to the Shenzhen Songhe Cell and Gene Industry Private Equity Investment Fund Partnership (Limited Partnership) (tentative name) 1000 Ten thousand yuan Investment amount, accounting for 0.67% of the investment.

According to the announcement, the partnership's main investment projects are cell and gene therapy, novel virus vectors, novel vaccine research and development and industrialization, genetic technology, biological breeding research and development and industrialization, and upstream industries required in these fields.